Preclinical validation of therapeutic targets predicted by tensor factorization on heterogeneous graphs
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Incorrect drug target identification is a major obstacle in drug discovery. Only 15% of drugs advance from Phase II to approval, with ineffective targets accounting for over 50% of these failures 1–3. Advances in data fusion and computational modeling have independently progressed towards addressing this issue. Here, we capitalize on both these approaches with Rosalind, a comprehensive gene prioritization method that combines heterogeneous knowledge graph construction with relational inference via tensor factorization to accurately predict disease-gene links. Rosalind demonstrates an increase in performance of 18%-50% over five comparable state-of-the-art algorithms. On historical data, Rosalind prospectively identifies 1 in 4 therapeutic relationships eventually proven true. Beyond efficacy, Rosalind is able to accurately predict clinical trial successes (75% recall at rank 200) and distinguish likely failures (74% recall at rank 200). Lastly, Rosalind predictions were experimentally tested in a patient-derived in-vitro assay for Rheumatoid arthritis (RA), which yielded 5 promising genes, one of which is unexplored in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buniello, A., MacArthur, J. A. L., Cerezo, M., Harris, L. W., Hayhurst, J., Malangone, C., McMahon, A., Morales, J., Mountjoy, E., Sollis, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1120 · Cited by 4,000
BioGRID: a general repository for interaction datasets
Stark, C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj109 · Cited by 3,960
Gene Ontology Consortium: going forward
The Gene Ontology Consortium (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1179 · Cited by 3,492
Piñero, J., Bravo, À., Queralt-Rosinach, N., Gutiérrez-Sacristán, A., Deu-Pons, J., Centeno, E., García-García, J., Sanz, F., & Furlong, L. I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw943 · Cited by 2,680
Zerbino, D. R., Achuthan, P., Akanni, W., Amode, M. R., Barrell, D., Bhai, J., Billis, K., Cummins, C., Gall, A., Girón, C. G., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1098 · Cited by 2,605
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Embedding Entities and Relations for Learning and Inference in Knowledge Bases
Yang, B., Yih, W.-T., He, X., Gao, J., & Deng, L. (2014) · arXiv · doi:10.48550/arxiv.1412.6575 · Cited by 2,252
Complex Embeddings for Simple Link Prediction
Trouillon, T., Welbl, J., Riedel, S., Gaussier, É., & Bouchard, G. (2016) · arXiv · doi:10.48550/arxiv.1606.06357 · Cited by 2,100
Modeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
The Expression of a Tensor or a Polyadic as a Sum of Products
Hitchcock, F. L. (1927) · Journal of Mathematics and Physics · doi:10.1002/sapm192761164 · Cited by 1,345
Cited by
Knowledge graphs and their applications in drug discovery
MacLean, F. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1910673 · Cited by 105
Expert-Augmented computational drug repurposing identified baricitinib as a treatment for COVID-19
Smith, D. P., Oechsle, O., Rawling, M. J., Savory, E., Lacoste, A. M. B., & Richardson, P. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709856 · Cited by 62
“We have described here how we enriched our biomedical knowledge graph (Paliwal et al., 2020) using NLP, using it to identify host biological processes and pathways that are impacted by SARS-CoV-2 infection.”
MethodSelf-citationFernández-Torras, A., Duran-Frigola, M., Bertoni, M., Locatelli, M., & Aloy, P. (2022) · Nature Communications · doi:10.1038/s41467-022-33026-0 · Cited by 59
“In general, the size of our KG is comparable to other recently published biomedical KGs 13,23 – 25 .”
Result
Metadata
- Authors
- Paliwal, S., de Giorgio, A., Neil, D., Michel, J.-B., & Lacoste, A. M.
- Venue
- Scientific Reports
- Published
- 2020-10-26
- Volume
- 10
- Issue
- 1
- Pages
- 18250-18250
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W3094062017
- Cited by
- 45
- References
- 17
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preclinical validation of therapeutic targets predicted by tensor factorization on heterogeneous graphs. https://app.cochat.ai/papers/10.1038/s41598-020-74922-z
- The paper
- Paliwal, S., de Giorgio, A., Neil, D., Michel, J.-B., & Lacoste, A. M. (2020). Preclinical validation of therapeutic targets predicted by tensor factorization on heterogeneous graphs. Scientific Reports. https://doi.org/10.1038/s41598-020-74922-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.